Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714714 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.
A Phase 4 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00714714 is a Phase 4 study that has completed, run by Bausch Health Americas. The registered enrollment target is 25 participants.
The verdict
NCT00714714, a Phase 4 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
Interventions
- DRUG Tretinoin Gel
- DRUG Adapalene Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00714714
The ClinicalTrials.gov registry entry for NCT00714714 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tretinoin Gel is the first listed.
NCT00714714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00714714 about?
NCT00714714 is a clinical study titled "Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.". A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
What is the current status of trial NCT00714714?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00714714?
The interventions under investigation include: Tretinoin Gel (DRUG), Adapalene Gel (DRUG).
Who is sponsoring clinical trial NCT00714714?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.